1. Home
  2. Labeler Index
  3. Baxter Healthcare Corporation
  4. 0338-1073
  5. NDC Package Code: 0338-1073-02 Dobutamine Hydrochloride In Dextrose

NDC Package 0338-1073-02 Dobutamine Hydrochloride In Dextrose

Dobutamine Hydrochloride Injection Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0338-1073-02
Package Description:
18 BAG in 1 CARTON / 250 mL in 1 BAG
Product Code:
0338-1073
Proprietary Name:
Dobutamine Hydrochloride In Dextrose
Non-Proprietary Name:
Dobutamine Hydrochloride
Substance Name:
Dobutamine Hydrochloride
Usage Information:
Dobutamine in 5% Dextrose Injection is indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures. Experience with intravenous dobutamine in controlled trials does not extend beyond 48 hours of repeated boluses and/or continuous infusions.Whether given orally, continuously intravenously, or intermittently intravenously, neither dobutamine nor any other cyclic-AMP-dependent inotrope has been shown in controlled trials to be safe or effective in the long-term treatment of congestive heart failure. In controlled trials of chronic oral therapy with various such agents, symptoms were not consistently alleviated, and the cyclic-AMP-dependent inotropes were consistently associated with increased risks of hospitalization and death. Patients with NYHA Class IV symptoms appeared to be at particular risk.
11-Digit NDC Billing Format:
00338107302
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 309985 - DOBUTamine 250 MG in 250 ML Injection
  • RxCUI: 309985 - 250 ML dobutamine 1 MG/ML Injection
  • RxCUI: 309985 - dobutamine (as dobutamine HCl) 250 MG per 250 ML Injection
  • RxCUI: 309985 - dobutamine 250 MG per 250 ML Injection
  • RxCUI: 309986 - DOBUTamine 500 MG in 250 ML Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Baxter Healthcare Corporation
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • DOBUTAMINE HYDROCHLORIDE 100 mg/100mL
    • Pharmacologic Class(es):
  • Adrenergic beta-Agonists - [MoA] (Mechanism of Action)
  • beta-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    NDA020255
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    09-27-1993
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 0338-1073-02 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    00338107302J1250Inj dobutamine hcl/250 mg250 MG25018118

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0338-1073-02?

    The NDC Packaged Code 0338-1073-02 is assigned to a package of 18 bag in 1 carton / 250 ml in 1 bag of Dobutamine Hydrochloride In Dextrose, a human prescription drug labeled by Baxter Healthcare Corporation. The product's dosage form is injection and is administered via intravenous form.

    Is NDC 0338-1073 included in the NDC Directory?

    Yes, Dobutamine Hydrochloride In Dextrose with product code 0338-1073 is active and included in the NDC Directory. The product was first marketed by Baxter Healthcare Corporation on September 27, 1993 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0338-1073-02?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 0338-1073-02?

    The 11-digit format is 00338107302. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20338-1073-025-4-200338-1073-02